Phathom Pharmaceuticals

Phathom passes acid tests, capturing 2 FDA approvals for Voquezna after impurity setback
Fierce Pharma
Thu, 11/2/23 - 05:13 pm
Phathom Pharmaceuticals
FDA
Voquezna
H. pylori
GERD
FDA decision, launch of gastrointestinal drug delayed after nitrosamine found in commercial batches
Endpoints
Wed, 01/4/23 - 10:03 am
Phathom Pharmaceuticals
Takeda
nitrosamine
vonoprazan
FDA
erosive esophagitis
11 drugs granted FDA fast track designation in 2022
Beckers Hospital Review
Wed, 08/24/22 - 10:55 pm
FDA
fast track
Agios Pharmaceuticals
CTI BioPharma
Bristol Myers Squibb
Nobel Biocare
BioXcel Therapeutics
Mycovia Pharmaceuticals
Phathom Pharmaceuticals
Mitsubishi Tanabe Pharma
SIGA technologies
Alnylam Pharmaceuticals
Phathom launches GI education effort aimed at doctors in advance of vonoprazan's FDA submissions
Fierce Pharma
Fri, 06/4/21 - 10:58 am
Phathom Pharmaceuticals
physicians
physician education
H. pylori
A tale of two IPOs (plus one): Cabaletta prices well below range for $75M while Phathom bags $182M
Endpoints
Sat, 10/26/19 - 02:22 pm
IPOs
Cabaletta Bio
Phathom Pharmaceuticals
The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict
Yahoo/Benzinga
Sun, 10/20/19 - 05:18 pm
earnings
Eli Lilly
Alexion
Gilead Sciences
Biomarin
Edwards Lifesciences
Baxter International
Integra LifeSciences
Phathom Pharmaceuticals
IPOs
Foamix
Eton Pharmaceuticals
Melinta Therapeutics
Ligand Pharmaceuticals